| |
Program
| |
 |
 |
Chemical Genomics – Whats’ in a name?
Ed Zanders, Cambridge Bioscience Partners, UK
|
[
Modem ]
[
DSL ]
|
|
Chemical space meets biological space now what?
Jordi Mestres, Municipal Institute of Medical Research, Barcelona
|
[
Modem ]
[
DSL ]
|
|
Chemogenomics knowledge-based strategies in drug discovery
Edgar Jacoby, Novartis, Switzerland
|
[
Modem ]
[
DSL ]
|
|
Empiric discovery of novel combination drugs using multi-dimensional Chemical Empiric discovery of novel combination drugs using multi-dimensional Chemical Genetics
Curtis Keith, CombinatoRX, USA
|
[
Modem ]
[
DSL ]
|
|
Chemiproteomics-driven drug discovery: increasing compound-target knowledge
Dr Steven Hall, Serenex, USA
|
[
Modem ]
[
DSL ]
|
|
Analogue-Sensitive Kinase Allel (ASKA) Technology: unique in vivo models for kinase drug discovery
J Andrew Whitney, Cellular Genomics Inc, USA
|
[
Modem ]
[
DSL ]
|
|
|
| |
| |
|
| |
| |
Webcast produced by
Prous Science 
RealNetworks, RealPlayer and RealAudio are trademarks of RealNetworks,
Inc.
|
|
